2023 Form 5500 filing — Teva Pharmaceuticals Usa, Inc. Employment Transition Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20251215145310NAL0003676594001) for Teva Pharmaceuticals Usa, Inc. Employment Transition Plan, reported by Teva Pharmaceuticals Usa, Inc. under EIN 22-1734359 and plan number 511. It reports 5,222 participants. Attached schedule details are not reported in the loaded dataset.
Filing snapshot
- EFAST2 acknowledgement
- 20251215145310NAL0003676594001
- Plan sponsor
- Teva Pharmaceuticals Usa, Inc.
- EIN
- 22-1734359
- Plan number
- 511
- Location
- Parsippany, NJ
- Received date
- not reported in the loaded dataset
Reported financial snapshot
Reported figures as filed, in whole dollars. Only fields the filing reports are shown.
This 2023 filing is loaded, but detailed Schedule H/I financial figures are not present for it in the current loaded dataset. Participant counts and filing identity above are reported; asset and contribution detail comes from the financial schedules where filed.